Clinical variables associated with mortality in patients with COVID-19
PDF (Español)

How to Cite

1.
Guzmán Sáenz RC, Sáenz López JD, Tatis Villamizar KE. Clinical variables associated with mortality in patients with COVID-19. Rev. Colomb. Nefrol. [Internet]. 2020 Jun. 3 [cited 2024 Apr. 18];7(Supl.2). Available from: https://revistanefrologia.org/index.php/rcn/article/view/457
https://doi.org/10.22265/acnef.7.Supl.2.457
PDF (Español)

References

World Health Organization (WHO). WHODirector-General’s opening remarks at the media briefing on COVID-19-11 March 2020. Ginebra: WHO; 2020. [citado 2020 May 30]. Disponible en: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020.

Aydemir D, Ulusu NN. Correspondence: Importance of the validated serum biochemistry and hemogram parameters for rapid diagnosis and to prevent false negative results during COVID-19 pandemic. Biotechnol App Biochem. 2020. https://doi.org/10.1002/bab.1936.

Singhal T. A Review of Coronavirus Disease-2019 (COVID-19). Indian J Pediatr. 2020;87(4):281-6. https://doi.org/10.1007/s12098-020-03263-6.

Fan BE, Chong VCL, Chan SSW, Lim GH, Lim KGE, Tan GB, et al. Hematologic parameters in patients with COVID?19 infection. Am J Hematol. 2020;95(6):E131-4. https://doi.org/10.1002/ajh.25774.

Zhang L, Yan X, Fan Q, Liu H, Liu X Liu Z, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid19. J Thromb Haemost. 2020;18(6):1324-9 https://doi.org/10.1111/jth.14859.

Ferrnari D, Motta A, Strollo M, Banfi G, Locatelli M. Routine blood tests as a potential diagnostic tool for COVID-19. Clin Chem LabMed. 2020;58(7):1095-9. https://doi.org/10.1515/cclm-2020-0398.

Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323(20):2052?9. https://doi.org/10.1001/jama.2020.6775.

Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531-8. https://doi.org/10.1007/s00392-020-01626-9.

No national or foreign publication may partially or totally reproduce or translate Revista Colombiana de Nefrología articles or abstracts without prior written permission from the journal’s Editorial Board.

Dimensions


PlumX


Downloads

Download data is not yet available.